HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...

Nobody has ever contracted HIV or hepatitis from toilet roll, as the viruses don't survive for long outside the body.

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...

In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating ...

New Delhi: Indian public health campaigners on Wednesday said they will oppose the patent applications of a promising new but ...

Standard treatment of babies with HIV typically starts two to three months after birth and continues for decades. This new ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

A new study reports that the type 2 diabetes drug metformin could help people living with HIV who are using antiretroviral drugs. In a previous study, after three months of using metformin ...

Drug companies typically only ensure drug access ... industry to grant permission for access while tens of thousands of new HIV infections accrue? In principle, solutions to enable access are ...

2024, 7, 8, 2379-2390) Efavirenz is an important drug for treating HIV infection ... a UMBC bioanalytical chemist and senior author on the new paper. “That formed the basis for investigating ...

The HIV drug which costs around $44,000 for twice-yearly ... Worldwide there are 1.3 million infections every year, with one new HIV infection every 24 seconds. Gilead has several patent ...